Stille

Stille Net Change in Cash

The Net Change in Cash of Stille (STIL.ST) as of Oct 24, 2026 is -39.83 M SEK. In the previous year, Net Change in Cash was -82.96 M SEK — a change of -52.00% (higher).

Net Change in Cash

-39.83 MSEK

YoY

-52.00%

Last updated:

Net Change in Cash of Stille is 2025 -39.83 M SEK. Net Change in Cash of Stille was 2024 -82.96 M SEK. It decreases by -52.00% higher compared to the previous year.

The Stille Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
3.20 M SEK
Jan 1, 2019
8.91 M SEK
Jan 1, 2020
-6.46 M SEK
Jan 1, 2021
-10.32 M SEK
Jan 1, 2022
8.88 M SEK
Jan 1, 2023
204.77 M SEK
Jan 1, 2024
-82.96 M SEK
Jan 1, 2025
-39.83 M SEK
The Stille Net Change in Cash history
YEARNet Change in CashYoY
-39.83 MSEK-52.00%
-82.96 MSEK-140.51%
204.77 MSEK+2,205.44%
8.88 MSEK-186.07%
-10.32 MSEK+59.68%
-6.46 MSEK-172.54%
8.91 MSEK+178.41%
3.20 MSEK+98.39%
1.61 MSEK-89.68%
15.63 MSEK+39.97%
11.16 MSEK-570.26%
-2.37 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Net Change in Cash of Stille is -39.83 M SEK in 2025.

Net Change in Cash of Stille changed from -82.96 M SEK to -39.83 M SEK, representing a -52.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Stille since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Stille historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Stille

All Key Metrics — Stille